In a triple whammy of good news, 1 October heralds the beginning of the funding of two major health products and a welcome contribution to early childhood fees, Prime Minister Christopher Luxon says.

A total of 27 women received the breast cancer vaccine and the clinical trial is preparing its second phase. Results are ...

Merck (MRK) is one of the worst-performing stocks in the Dow Jones Industrial Average (DJIA) on Thursday. The US government ...

Hot on the tail of AstraZeneca’s Imfinzi, Bristol Myers Squibb’s PD-1/L1 inhibitor Opdivo has expanded its non-small cell lung cancer (NSCLC) net with an ...

Summit is up 670 per cent this year, bringing its market capitalization to US$14.5 billion. Over 52 weeks, it is up an ...

As the nights draw in Bryony Fernandez is preparing for the next phase of helping her fiancé, Jon Ward, to access the ...

Dealmaking is up this year and doesn’t look like it will slow down in 2025. Merck is an example of a company that could easily buy a smaller one.

Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.

Services Australia advises AMA members of PBS changes that have recently come into effect. Services Australia has released ...

The FDA greenlighted Bristol Myers Squibb’s Opdivo for use before and after surgery for non-small cell lung cancer. A regimen ...

Health New Zealand's latest report shows encouraging improvements in cancer treatment wait times, emergency department ...

Sep. 10, 2024 — Phase separation, when molecules part like oil and water, works alongside oxygen diffusion to help memristors -- electrical components that store ... Electrically Modulated Light ...